A Study of Peptide Receptor Radionuclide Therapy (PRRT) Use in Neuroendocrine Tumor (NET) Patients in Germany
Clinical trial NCT07653126 · COMPLETED
Trial details
- NCT number
- NCT07653126
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-04-03
- Primary completion
- 2023-09-29
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.